Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.73%
#4 Black Phoenix Black Phoenix +335.34%
#5 aPriori aPriori +115.80%
#6 Bedrock Bedrock +73.38%
#7 Cysic Cysic +44.55%
#8 Prom Prom +41.94%
#9 COTI COTI +35.38%
#10 Playnance Playnance +34.37%
Coin of the day
Wrapped One Wrapped One
Settings
Language
ENGLISH
Currency
USD
Theme
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Rank in Stocks #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Share Price
$0.85
Last synced: 2025-01-21
Market Cap
$411.40
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Fresh2 Group Limited (FRES)

Category

Healthcare
Earnings for Fresh2 Group Limited (FRES)
Earnings in Jun 2023 TTM: $-13.66M
According to Fresh2 Group Limited latest financial reports the company's current earnings are $-13.66M. In 2021 the company made an earning of $-18.85M, a decrease compared to its 2020 earnings that were of $-11.67M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Fresh2 Group Limited from 2017 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-13.66M -10.89%
2022 $-15.33M -18.70%
2021 $-18.85M 61.55%
2020 $-11.67M -20.14%
2019 $-14.61M 130.04%
2018 $-6.35M 7.85%
2017 $-5.89M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -38,721.23%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -14,382.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -22,106.96%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR